TBPs | Prevalence (%) of TBPs | ||||||||
---|---|---|---|---|---|---|---|---|---|
Yaks | Tibetan sheep | Total | |||||||
Guoluo | Yushu | Total | Guoluo | Yushu | Total | Guoluo | Yushu | Total | |
(n = 210) | (n = 215) | (n = 425) | (n = 183) | (n = 126) | (n = 309) | (n = 393) | (n = 341) | (n = 734) | |
Anaplasma ovis (A. o.) | 0 | 0 | 0 | 1 (0.5) | 13 (10.3) | 14 (4.5) | 1 (0.3) | 13 (3.8) | 14 (1.9) |
Anaplasma bovis (A. b) | 13 (6.2) | 14 (6.5) | 27 (6.4) | 3 (1.6) | 0 | 3 (1.0) | 16 (4.1) | 14 (4.1) | 30 (4.1) |
Anaplasma capra (A. c.) | 0 | 0 | 0 | 7 (3.8) | 7 (5.6) | 14 (4.5) | 7 (1.8) | 7 (2.1) | 14 (1.9) |
Anaplasma phagocytophilum (A. p.) | 0 | 0 | 0 | 1 (0.5) | 28 (22.2) | 29 (9.4) | 1 (0.3) | 28 (8.2) | 29 (4.0) |
Babesia bovis (B. bo.) | 5 (2.4) | 14 (6.5) | 19 (4.5) | 0 | 0 | 0 | 5 (1.3) | 14 (4.1) | 19 (2.6) |
Theileria spp. (T.) | 6 (2.9) | 7 (3.3) | 13 (3.1) | 5 (2.7) | 2 (1.6) | 7 (2.3) | 11 (2.8) | 9 (2.6) | 20 (2.7) |
A. o. + A. b. | 0 | 0 | 0 | 4 (2.2) | 0 | 4 (1.3) | 4 (1.0) | 0 | 4 (0.5) |
A. o. + A. c. | 0 | 0 | 0 | 13 (7.1) | 10 (7.9) | 23 (7.4) | 13 (3.3) | 10 (2.9) | 23 (3.1) |
A. o. + A. p. | 0 | 0 | 0 | 0 | 2 (1.6) | 2 (0.6) | 0 | 2 (0.6) | 2 (0.3) |
A. o. + T. | 0 | 0 | 0 | 0 | 4 (3.2) | 4 (1.3) | 0 | 4 (1.2) | 4 (0.5) |
A. b. + A. c. | 0 | 0 | 0 | 2 (1.1) | 0 | 2 (0.6) | 2 (0.5) | 0 | 2 (0.3) |
A. b. + A. p. | 0 | 0 | 0 | 0 | 1 (0.8) | 1 (0.3) | 0 | 1 (0.3) | 1 (0.1) |
A. c. + A. p. | 0 | 0 | 0 | 2 (1.1) | 0 | 2 (0.6) | 2 (0.5) | 0 | 2 (0.3) |
A. c. + T. | 0 | 0 | 0 | 13 (7.1) | 1 (0.8) | 14 (4.5) | 13 (3.3) | 1 (0.3) | 14 (1.9) |
A. p. + T. | 0 | 0 | 0 | 1 (0.5) | 0 | 1 (0.3) | 1 (0.3) | 0 | 1 (0.1) |
B. bo. + T. | 0 | 1 (0.5) | 1 (0.2) | 0 | 0 | 0 | 0 | 1 (0.3) | 1 (0.1) |
A. o. + A. b. + A. c. | 0 | 0 | 0 | 17 (9.3) | 0 | 17 (5.5) | 17 (4.3) | 0 | 17 (2.3) |
A. o. + A. b. + T. | 0 | 0 | 0 | 5 (2.7) | 0 | 5 (1.6) | 5 (1.3) | 0 | 5 (0.7) |
A. o. + A. c. + A. p. | 0 | 0 | 0 | 6 (3.3) | 0 | 6 (1.9) | 6 (1.5) | 0 | 6 (0.8) |
A. o. + A. c. + T. | 0 | 0 | 0 | 22 (12.0) | 1 (0.8) | 23 (7.4) | 22 (5.6) | 1 (0.3) | 23 (3.1) |
A. o. + A. p. + T. | 0 | 0 | 0 | 3 (1.6) | 0 | 3 (1.0) | 3 (0.8) | 0 | 3 (0.4) |
A. b. + A. c. + T. | 0 | 0 | 0 | 11 (6.0) | 0 | 11 (3.6) | 11 (2.8) | 0 | 11 (1.5) |
A. o. + A. b. + A. c. + A. p. | 0 | 0 | 0 | 3 (1.6) | 0 | 3 (1.0) | 3 (0.8) | 0 | 3 (0.4) |
A. o. + A. b. + A. c. + T. | 0 | 0 | 0 | 46 (25.1) | 0 | 46 (14.9) | 46 (11.7) | 0 | 46 (6.3) |
A. o. + A. c. + A. p. + T. | 0 | 0 | 0 | 11 (6.0) | 0 | 11 (3.6) | 11 (2.8) | 0 | 11 (1.5) |
A. o. + A. b. + A. c. + A. p. + T. | 0 | 0 | 0 | 2 (1.1) | 0 | 2 (0.6) | 2 (0.5) | 0 | 2 (0.3) |
Total mixed infections | 0 | 1 (0.5) | 1 (0.2) | 161 (88.0) | 19 (15.1) | 180 (58.3) | 161 (41.0) | 20 (5.9) | 181 (24.7) |
Total positive | 24 (11.4) | 36 (16.7) | 60 (14.1) | 178 (97.3) | 69 (54.8) | 247 (79.9) | 202 (51.4) | 105 (30.8) | 307 (41.8) |